PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1673002
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1673002
Global Oral Thin Films Market is estimated to be valued at USD 3.40 Bn in 2025 and is expected to reach USD 6.46 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 3.40 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 9.60% | 2032 Value Projection: | USD 6.46 Bn |
Oral thin films are sublingual or buccal drug delivery systems that are placed on the tongue or inner cheek. They rapidly dissolve to release the active pharmaceutical ingredient which is absorbed directly into the bloodstream, bypassing the gastrointestinal tract and liver. This results in the faster absorption of the drug, greater bioavailability, and quick onset of action. Oral thin films are very convenient and easy to administer, without the need of water compared to tablets and capsules. Their portability and fast dissolving nature makes them popular for emergency drugs, pediatric, and geriatric cases. This trend is fueling growth of the global oral thin films market in the coming years.
Emerging technologies to produce thinner and faster dissolving films, increasing preference for convenient oral dosage forms, and rising demand for pediatric and geriatric dosage forms are some of the key drivers propelling the oral thin films market. Portable packaging and long shelf life without refrigeration requirement is boosting the popularity of thin films in developing regions. Manufacturers are investing in new polymer films and saliva-activated adhesives to develop novel products with enhanced stability and taste masking capacity. For instance, in May 2021, a study published by ResearchGate highlights the growing preference for convenient oral dosage forms, indicating an increased demand for pediatric and geriatric formulations. Children's medicine preferences in Europe are influenced by age, experience, and health, rather than gender. Taste and ease of swallowing are important factors, with liquid medicine favored by younger, healthier children, and pills preferred by older or chronically ill kids. Less common forms like dissolvable films or granules are less popular. Country-specific differences exist, with Spanish children preferring liquid medicine and Dutch children favoring small pills. These insights boost the development of preferred oral dosage forms, emphasizing the need for convenient oral options in pediatric and geriatric care.
Detailed Segmentation-